HemaSphere
(Jun 2022)
P616: THE LOSS OF IΚBΕ INHIBITOR ACCELERATES DISEASE DEVELOPMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
- C. Lenzi,
- J. Bordini,
- A. Pseftogkas,
- A. Morabito,
- G. Tsiolas,
- F. E. Psomopoulos,
- A. Campanella,
- M. Frenquelli,
- P. Ghia
Affiliations
- C. Lenzi
- 1 Division of Experimental Oncology, Università Vita-Salute San Raffaele
- J. Bordini
- 2 Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
- A. Pseftogkas
- 1 Division of Experimental Oncology, Università Vita-Salute San Raffaele
- A. Morabito
- 2 Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
- G. Tsiolas
- 3 Center for Research and Technology Hellas-CERTH, Thessaloniki, Greece
- F. E. Psomopoulos
- 3 Center for Research and Technology Hellas-CERTH, Thessaloniki, Greece
- A. Campanella
- 1 Division of Experimental Oncology, Università Vita-Salute San Raffaele
- M. Frenquelli
- 2 Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
- P. Ghia
- 1 Division of Experimental Oncology, Università Vita-Salute San Raffaele
- DOI
-
https://doi.org/10.1097/01.HS9.0000845352.28969.97
- Journal volume & issue
-
Vol. 6
pp.
515
– 516
WeChat QR code